CVS Health EBITDA 2012-2026 | CVS
CVS Health annual and quarterly EBITDA history from 2012 to 2026. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- CVS Health EBITDA for the quarter ending March 31, 2026 was $3.259B, a 7.28% decline year-over-year.
- CVS Health EBITDA for the twelve months ending March 31, 2026 was $14.991B, a 14.32% increase year-over-year.
- CVS Health 2025 annual EBITDA was $14.991B, a 14.32% increase from 2024.
- CVS Health 2024 annual EBITDA was $13.113B, a 27.59% decline from 2023.
- CVS Health 2023 annual EBITDA was $18.109B, a 48.7% increase from 2022.
|
CVS Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $14,991 |
| 2024 | $13,113 |
| 2023 | $18,109 |
| 2022 | $12,178 |
| 2021 | $18,227 |
| 2020 | $18,352 |
| 2019 | $16,358 |
| 2018 | $12,888 |
| 2017 | $12,198 |
| 2016 | $12,861 |
| 2015 | $11,567 |
| 2014 | $10,730 |
| 2013 | $9,907 |
| 2012 | $8,963 |
| 2011 | $7,899 |
|
CVS Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-12-31 | $3,259 |
| 2025-09-30 | $3,652 |
| 2025-06-30 | $3,552 |
| 2025-03-31 | $4,528 |
| 2024-12-31 | $3,515 |
| 2024-09-30 | $1,993 |
| 2024-06-30 | $4,196 |
| 2024-03-31 | $3,409 |
| 2023-12-31 | $4,507 |
| 2023-09-30 | $4,817 |
| 2023-06-30 | $4,338 |
| 2023-03-31 | $4,447 |
| 2022-12-31 | $4,702 |
| 2022-09-30 | $-2,869 |
| 2022-06-30 | $5,751 |
| 2022-03-31 | $4,594 |
| 2021-12-31 | $3,435 |
| 2021-09-30 | $4,626 |
| 2021-06-30 | $5,463 |
| 2021-03-31 | $4,703 |
| 2020-12-31 | $3,663 |
| 2020-09-30 | $4,363 |
| 2020-06-30 | $5,782 |
| 2020-03-31 | $4,544 |
| 2019-12-31 | $4,133 |
| 2019-09-30 | $4,020 |
| 2019-06-30 | $4,404 |
| 2019-03-31 | $3,801 |
| 2018-12-31 | $3,859 |
| 2018-09-30 | $3,194 |
| 2018-06-30 | $3,195 |
| 2018-03-31 | $2,640 |
| 2017-12-31 | $3,797 |
| 2017-09-30 | $3,114 |
| 2017-06-30 | $2,875 |
| 2017-03-31 | $2,412 |
| 2016-12-31 | $3,648 |
| 2016-09-30 | $3,435 |
| 2016-06-30 | $2,976 |
| 2016-03-31 | $2,802 |
| 2015-12-31 | $3,332 |
| 2015-09-30 | $2,863 |
| 2015-06-30 | $2,750 |
| 2015-03-31 | $2,622 |
| 2014-12-31 | $2,810 |
| 2014-09-30 | $2,723 |
| 2014-06-30 | $2,696 |
| 2014-03-31 | $2,501 |
| 2013-12-31 | $2,675 |
| 2013-09-30 | $2,615 |
| 2013-06-30 | $2,421 |
| 2013-03-31 | $2,196 |
| 2012-12-31 | $2,740 |
| 2012-09-30 | $2,257 |
| 2012-06-30 | $2,139 |
| 2012-03-31 | $1,827 |
| 2011-12-31 | $2,354 |
| 2011-09-30 | $1,991 |
| 2011-06-30 | $1,875 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $101.670B | $402.067B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |